Insulin fibrillation is a limiting factor for its long-term storage because of considerably reduced bioavailable moieties. Deposition of fibrillated insulin can also cause subcutaneous insulin amyloidoma. Toxic phenolic compounds along with Zinc are used during commercial preparation of insulin to stabilize it in a hexameric form. Designed or repurposed natural small molecules with anti-amyloidogenic properties could thus be attractive agents for preventing insulin fibrillation. Natural polyphenolic compounds which have been shown to serve as anti-amyloid agents for proteins associated with neurodegenerative diseases are potential candidates for such function.
Introduction
The anti-hyperglycemic hormone insulin is widely used as a drug for type 1 and in some cases type 2 diabetes. It is a 51-residue globular protein consisting of 21 residues long Achain and 30 residues long B-chain that are connected by 2 disulfide bridges [1] (Figure S1 ).
The structural analysis confirms that the A-chain contains a helical hairpin whereas B-chain consists of a single helix [2] . In the pancreatic -cells, insulin is stored as an inactive hexameric assembly stabilized by zinc ions [3, 4] and following secretion into blood, high dilution and change of pH induce its dissociation into dimer and subsequently into a biologically active monomer [5] . In solution, insulin apparently coexists with a dimer, tetramer, hexamer, or other higher-order multimers in equilibrium [6] . Although monomeric insulin is the active form of the hormone, insulin monomer is less stable than the Zn 2+ -coordinated hexameric form and is prone to aggregation [7] . Mechanistically, the unfolded insulin monomer with exposed hydrophobic regions triggers amyloidogenesis [8] , with the typical cross-β structure as that of mature fibrils of other disease causing amyloids [9] , and thus belongs to the category of natively structured amyloidogenic proteins.
The presence of insulin amyloid fibrils has been reported in patients with diabetes as well as in normal aging [9, 10] . Increasing number of evidence has been accumulated on insulin amyloidoma, a medical condition in diabetes patients where extracellular insulin fibrils are found at the site of insulin injection [11, 12] , that may also lead to poor penetration of the injected insulin and variable insulin response [7] . Moreover, insulin fibrillation has been a limiting factor in the long-term storage of insulin, causing reduced bioavailability of the existing insulin formulations [7, 13] and impairment of the efficiency of insulin delivery systems such as insulin pumps [7] .
Commercially available insulin analogs are formulated with stabilizing excipients such as m-cresol and other phenolic products to avoid or minimize fibrillation and provide enhanced stability [14, 15] . Nevertheless, recent literature raised a relevant question about the toxicity of insulin formulations. Reports suggest pure m-cresol, phenol, and even insulin formulations, display enhanced cytotoxicity and proinflammatory response, resulting in significant cell death, when they are exposed to certain dosage [16, 17] . Due to their adverse cytotoxic and proinflammatory effects, phenolic derivatives can potentially act as toxins in the kidneys, skin, liver, respiratory, gastrointestinal, cardiovascular and central nervous systems [18] . Several years of exposure to this toxin renders higher susceptibility to develop tumors [19] , demonstrating its carcinogenic potential. Thus, repeated dosage of insulin formulations containing m-cresol or other phenolic compounds may raise serious medical concern for diabetic patients. Therefore, any nontoxic molecule that stabilizes insulin oligomers and at the same time permits the release of fast-acting monomeric active form has a potential clinical utility. A very recent study has demonstrated a chemical synthesis approach for producing biologically active insulin variant [20] .
Various small molecules, peptides, oligomer-or amyloid-specific antibodies are known to act as effective inhibitors of protein fibrillation [21] . Few studies have reported inhibitory effects of small molecules such as epigallocatechin gallate (EGCG), quercetin or quinones on insulin fibrillation [22] . Among the small molecules, naturally occurring polyphenols have definite advantages since they are non-toxic at moderate concentrations and stable in serum without having an immune response [23] . Interestingly, emerging evidence suggests that ingestion of polyphenol-rich pomace improves insulin sensitivity [24, 25] .
Here, we have examined the anti-aggregation potential of naturally occurring polyphenols on the fibrillation of human insulin under close to physiological conditions and explored the degree of efficacy of three naturally occurring polyphenolic compounds ( Figure   S1a -c) as anti-amyloidogenic factors for insulin ( Figure S1d ,e). Our study reveals that while all polyphenols are effective in reducing insulin fibrillation to a variable extent, the resveratrol in particular, abundantly found in red wine, chocolate and other dietary products, exhibits the strongest effect. More importantly, resveratrol-stabilized insulin has comparable glucose lowering activity to native insulin, suggesting that resveratrol-stabilized oligomers are capable of efficiently releasing active insulin monomers. Our structural analysis reveals that resveratrol-stabilized insulin adopts a tri-lobed globular shape resembling native insulin hexamer conformation.
Unlike fibrillation involved in neurodegenerative diseases, insulin fibrillation not only complicates the disease but also reduces availability of active insulin molecules. Our results demonstrate that resveratrol inhibits the fibrillation process of insulin at high temperature in such a way that active insulin molecules get stabilized. Thus, resveratrol can be a potential nontoxic stabilizer molecule for preserving insulin.
Results

Resveratrol inhibits insulin fibrillation differently compared to other polyphenolic compounds
We have investigated insulin fibrillation under conditions closely resembling a physiological one (pH 7.4) [26] , in contrast to the common experimental conditions of insulin fibrillation, such as low pH, extremely high temperature, high concentration of salts, and/or the presence of organic solvent [27, 28] . The anti-aggregation properties of three native polyphenols, resveratrol (trans-3, 4, 5-trihydroxystilbene, RES), epigallocatechin gallate (EGCG) and curcumin (CUR), along with flavanone glycoside-hesperidin (HES), were tested for human insulin aggregation using Thioflavin T (Th-T) fluorescence. Insulin, purchased from SIgma, had no phenolic additives. A significant decrease in fluorescence intensities was seen when polyphenols were incubated for 24 h with insulin in the equimolar ratio ( Figure S2a ). In contrast, another bioflavonoid, HES (which is not a polyphenol), did not show similar effect indicating specific insulin anti-aggregation role of polyphenols.
This observation prompted us to visualize the polyphenol-induced morphological changes during insulin oligomerization. The effect of polyphenols on insulin fibrillation was examined using atomic force microscopy (AFM). The AFM image revealed that insulin fibrils formed in the absence of polyphenols (Figure 1a ). In contrast, discrete spherical oligomers were the predominant species observed in the presence of an equimolar concentration of resveratrol to insulin (Figure 1b) , whereas a mixed population of insulin oligomers (much larger in size) was found when insulin was treated with EGCG or curcumin ( Figure 1c and 1d).
To gain insight into the sizes of insulin oligomers in the presence of polyphenols more precisely, transmission electronic microscopy (TEM) visualization was done. TEM image manifested a mesh of insulin aggregates characterized as linear and complexly intertwined fibrils ( Figure 1e ). Samples co-incubated with the polyphenolic compounds showed strong anti-aggregation effect (Figure 1f-1h) . Interestingly, tiny dotted structure (<20nm), with regular shape and size, was observed only in the presence of resveratrol (Figure 1f ). In the presence of EGCG or curcumin, on the other hand, short irregular protofibril-like structures were found buried in the amorphous aggregates (Figure 1g and 1h) .
We used Th-T fluorescence to visualize insulin fibrillation under a confocal microscope as well, which also showed significantly lower population of amyloid structures upon polyphenol treatments (Figure 1i-l) , particularly in the presence of resveratrol (Figure 1j ). It should be noted here that, although imaging using imaging using Th-T fluorescence can detect oligomers with cross β-sheet structures characteristic of amyloid fibers, it lacks the proper resolution to differentiate between fibrillar species present in the aggregates.
Visualizations of polyphenol-mediated anti-fibrillation phenomena revealed remarkable differences in size and shape of insulin aggregates in the presence of resveratrol as compared to other two polyphenols. It seemed from a dose-dependent study that resveratrol is effective when used at 1:0.5 or more of insulin:resveratrol ratio ( Figure S3 ).
Long-term effect of insulin fibrillation inhibition by the polyphenols
We further sought to investigate long-term effects of the polyphenols on insulin fibrillation.
The increase in Th-T fluorescence intensity was observed after 4h of agitation at 65 
Resveratrol stabilizes the population of a hexameric species of insulin molecule
The observation that oligomers formed upon resveratrol treatment preserve well the biological activity of insulin, instigated us to characterize structurally the dominant oligomeric species stabilized by resveratrol so that the mechanism of resveratrol-mediated stabilization of insulin can be discerned. 3D representation of the AFM images revealed that To understand the mechanism underlying its anti-fibrillation effect, we set out to determine the 3D structure of the major oligomeric form of resveratrol-treated insulin using cryo-EM. Isolated single units of insulin oligomeric species with distinct morphology were observed evenly dispersed in cryo-EM micrographs ( Figure 4a ). Single particle 3D reconstruction technique was employed to generate the 3D structure of the resveratrolstabilized insulin molecule. The reference free initial models, generated using EMAN2 [29] and Frealign [30] image processing software, had a globular shape which showed overall resemblance with the published crystal structures of insulin hexamer. The 2D class averages also showed spherical nature of the oligomer (Figure 4b ). The final 3D cryo-EM map (~14Å gold standard resolution) generated using SPIDER [31] (no symmetry applied) showed a globular structure with three lobes bulging out ( Interestingly, when we performed refinement of each dimeric unit (without any ligand) of the hexamer crystal structure (using GalaxyWeb server), we found that the refined molecular model of the insulin hexamer showed an expanded conformation compared to the hexamer crystal structure ( Figure S1f ) indicating that an intrinsic tendency of relaxation is likely present in the hexamer structure of insulin (closely compact due to the presence of phenolic derivatives).
Structural characterization of a resveratrol-stabilized oligomeric form of insulin
We performed an intrinsic fluorescence quenching experiment to determine interaction patterns of resveratrol with native insulin,. It was observed that intrinsic fluorescence level of insulin was decreased gradually in the presence of increasing concentration of resveratrol In order to decipher the binding sites of resveratrol within insulin hexamer, we performed docking studies on the atomic structure of insulin hexamer using commercially available docking software. We used the refined model structure ( Figure S1f ) of the insulin hexamer for docking in PatchDock server [32] . Top ten docked structures predicted by PatchDock showed that resveratrol molecules preferably occupy the interface of two dimeric modules ( Figure 5 ). Crystallographic studies of insulin hexamer containing m-cresol molecules (or resorcinol, PDB code 1EVR) confirmed that m-cresol helps to stabilize the insulin hexamer structure in an active form [14, 33] and the crystal structures revealed that at least two phenolic derivatives (m-cresol/resorcinol) are placed at the interface of two dimers in a hexameric insulin molecule (Figure 5b ), position-wise very similar to the resveratrol docking sites (Figure 5c ). The strategic orientation of two phenolic groups in resveratrol molecule ( Figure S1a ) allows one resveratrol molecule to intercalate within a pair of insulin dimers to stabilize the hexameric structure, whereas two phenolic derivatives are required for such stabilization (Figure 5d ). Notably, other docking servers e.g. SwissDock [34] and Autodock [35] also identified the pocket formed between two adjacent dimers in the hexameric structure as the potential binding region for resveratrol.
Combining the results of binding and docking studies we put forward a model of insulin hexamer stabilized by three resveratrol molecules, each accommodated at the interface of two adjacent dimers.
Discussion
Injectable insulin remains the mainstay of diabetes therapy and developing newer formulations of insulin with better stability and stringently controlled duration of action are still the major challenges in clinics [36, 37] . Amyloidogenesis of insulin poses a stumbling block for reduced bioavailability during long-term storage [13] . Thus, identification of a nontoxic stabilizer that not only inhibits insulin fibrillation but also preserves its bioactivity has immense clinical importance.
Here we found that resveratrol, a natural polyphenol, not only blocks the amyloid formation of insulin, but that the resveratrol-bound insulin retains biological activity.
Bioactivity of resveratrol-stabilized insulin both in vitro and in vivo clearly suggests enriched bioavailability of the active insulin monomer from resveratrol-stabilized insulin in comparison with native insulin undergoing fibrillation. Together, these findings reveal resveratrol as a potent insulin stabilizer showing anti-aggregating property by stacking insulin monomers into a stable hexameric form that fully retains its physiological activity.
Pharmaceutically formulated insulin contains phenolic compounds in combination with zinc ion (Zn 2+ ) to stabilize insulin in hexameric form [14] . Structural studies manifested that some phenolic additives such as phenol, m-cresol or resorcinol promote subtle change in conformation of 1-8 residues of the shorter chain (chain B) from extended to helical structure and induce the transition of a hexameric assembly of insulin from inactive, less stable tensed (T) (T 6 hexamers) state, to more active and stable relaxed (R) conformational state (R 6 insulin) [14, 15, [38] [39] [40] . However, phenolic excipients are toxic in nature [16, 17] . This concern prompted us to think about resveratrol as a potent nontoxic insulin stabilizing agent and a prospective substitution for m-cresol for stabilizing insulin in a bioactive form.
Corollary investigation using structural characterization by Cryo-EM depicted a possible mechanism of resveratrol-mediated anti-fibrillation through stabilizing an active hexameric 
Methods
Preparation of insulin fibrils
Recombinant human insulin (hINS) powder (Sigma Aldrich) was dissolved in 20 mM HCl (pH 2), and the pH of the solution was immediately adjusted to 8 using 100 mM NaOH.
Before incubation, the insulin solution was diluted with PBS (137 mM NaCl, 2.7 mM KCl, 
Thioflavin T assay
Thioflavin T (Th-T) dye binds specifically to the cross-β sheet structure of amyloid fibers and fluoresces more intensely in bound state [7] . 
Isothermal titration calorimetry (ITC)
The interaction studies of native insulin with resveratrol were performed on Affinity ITC (TA Instruments, USA). Titration was performed in presence of 20 μM native insulin and 200 μM of resveratrol in PBS (pH 7.4) at 298K. All the solutions were extensively degassed before measurement to avoid bubble formation inside the colorimeter cell. During titration 2 μl of the resveratrol was injected to insulin containing cell at an interval of 300s. The bufferresveratrol scan was subtracted from the insulin-resveratrol titration to correct the heat effects. The data were analysed and fitted by Nano Analyze software. Thermodynamic parameters were extracted for insulin-resveratrol interaction using the same software.
Atomic Force Microscopy (AFM)
Insulin samples (100 μM) in the absence and in the presence of 100 μM resveratrol were Two-dimensional (2D) reference-free class averages were computed by e2refine2d.py on the particle image sets. Same set of raw particles were subjected to classification independently in cisTEM (Frealign) [30, 42] , and Xmipp [43] (implemented in SCIPION cryo-EM image processing framework (http://scipion.cnb.csic.es/m/home/). About 11000 particles were used in the particle dataset. Initial models were created in EMAN2 and Frealign which look similar to the crystal structure of the insulin hexamer.
We have generated final 3D density map (~14Å resolution, Figure S5 ) in SPIDER (using new version where 'gold standard' refinement protocol has been implemented) using low pass filtered crystal structure (filtered to ~25Å) as the initial model. To further validate the 3D structure of the oligomer, the 3D density map was also generated in Frealign (available in SCIPION) and EMAN2 using same particle set, which also resulted very similar final maps in shape and sizes.
Modelling and docking
Fitting of the insulin dimer structure in each of the lobes of cryo-EM density map was done initially in Pymol (Delano Scientific) manually and then the model was subjected to molecular dynamics based fitting in MDFF [44] treating each of the dimer as a rigid body.
'Refine' module in GalaxyWeb server [45] (http://galaxy.seoklab.org/) was used for refining the dimeric units of insulin hexamer crystal structure (PDB ID:1EV6). Removal of ligands (e.g. Zn 2+ ion, m-cresol etc.) from the PDB structure was done prior to uploading it to the server. Refined model structure of the insulin hexamer and resveratrol 3D structure (taken from a crystal structure, PDB ID: 2JIZ) were used for docking in PatchDock server [32] which is a molecular docking algorithm based on shape complementarity principle. Docking in PatchDock using insulin crystal structure and resveratrol was also done which resulted in same docking positions of the ligand inside the hexameric structure of the protein. The docking performed using Autodock [46] and SwissDock servers [34] also identified the region at the interface of two dimeric units as the primary binding sites of resveratrol.
For creating illustrations, Chimera [47] and Pymol were used.
Cell lysis and Immunoblotting
Cells were rinsed with ice-cold PBS and total cellular protein was prepared with lysis buffer containing 50 mM Tris-HCl (pH 7.4), 100 mM NaCl, 1 mM EDTA, 1 mM EGTA and 1%
Triton X-100 with protease and phosphatase inhibitor cocktails both from (Millipore, (generated in EMDB web server (https://www.ebi.ac.uk/pdbe/emdb/ validation/fsc/)) of the single particle 3D reconstruction (done using newly developed gold standard protocol in SPIDER) of resveratrol-stabilized insulin.
